Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients with Arthritis (PRECISE)
What is the goal of the study?
Observational study of the impact of obesity on the pharmacokinetics (PK) and pharmacodynamics (PD) of biologic drugs administered as standard of care in rheumatoid arthritis (RA), Psoriatic Arthritis (PsA), and juvenile idiopathic arthritis (JIA)
Who can participate in the study?
Please contact the study team listed below to learn more.